Skip to main content
Patient-Centered Outcomes Research Institute
Patient-Centered Outcomes Research Institute
  • Blog
  • Newsroom
  • Find It Fast
  • Help Center
  • Subscribe
  • Careers
  • Contact Us

PCORI

Patient-Centered Outcomes Research Institute

Search form

  • About Us
    Close mega-menu

    About Us

    • Our Programs
    • Governance
    • Financials and Reports
    • Procurement Opportunities
    • Our Staff
    • Our Vision & Mission
    • Contact Us

    Fact Sheets: Learn More About PCORI

    Download fact sheets about out work, the research we fund, and our programs and initiatives.

    Find It Fast

    Browse through an alphabetical list of frequently accessed and searched terms for information and resources.

    Subscribe to PCORI Email Alerts

    Sign up for weekly emails to stay current on the latest results of our funded projects, and more.

  • Research & Results
    Close mega-menu

    Research & Results

    • Explore Our Portfolio
    • Research Fundamentals
    • Research Results Highlights
    • Putting Evidence to Work
    • Peer Review
    • Evidence Synthesis
    • About Our Research

    Evidence Updates from PCORI-Funded Studies

    These updates capture highlights of findings from systematic reviews and our funded research studies.

    Journal Articles About Our Funded Research

    Browse through a collection of journal publications that provides insights into PCORI-funded work.

    Explore Our Portfolio of Funded Projects

    Find out about projects based on the health conditions they focus on, the state they are in, and if they have results.

  • Topics
    Close mega-menu

    Topics

    • Addressing Disparities
    • Arthritis
    • Asthma
    • Cancer
    • Cardiovascular Disease
    • Children's Health
    • Community Health Workers
    • COVID-19
    • Dementia and Cognitive Impairment
    • Diabetes
    • Kidney Disease
    • Medicaid
    • Men's Health
    • Mental and Behavioral Health
    • Minority Mental Health
    • Multiple Chronic Conditions
    • Multiple Sclerosis
    • Obesity
    • Older Adults' Health
    • Pain Care and Opioids
    • Rare Diseases
    • Rural Health
    • Shared Decision Making
    • Telehealth
    • Transitional Care
    • Veterans Health
    • Women's Health

    Featured Topic: Women's Health

    Learn more about the projects we support on conditions that specifically or more often affect women.

  • Engagement
    Close mega-menu

    Engagement

    • The Value of Engagement
    • Engagement in Health Research Literature Explorer
    • Influencing the Culture of Research
    • Engagement Awards
    • Engagement Resources
    • Engage with Us

    Engagement Tools and Resources for Research

    This searchable peer-to-peer repository includes resources that can inform future work in patient-centered outcomes research.

    Explore Engagement in Health Literature

    This tool enables searching for published articles about engagement in health research.

    Research Fundamentals: A New On-Demand Training

    It enables those new to health research or patient-centered research to learn more about the research process.

  • Funding Opportunities
    Close mega-menu

    Funding Opportunities

    • What & Who We Fund
    • What You Need to Know to Apply
    • Applicant Training
    • Merit Review
    • Awardee Resources
    • Help Center

    PCORI Funding Opportunities

    View and learn about the newly opened funding announcements and the upcoming PFAs in 2021.

    Tips for Submitting a Responsive LOI

    Find out what PCORI looks for in a letter of intent (LOI) along with other helpful tips.

    PCORI Awardee Resources

    These resources can help awardees in complying with the terms and conditions of their contract.

  • Meetings & Events
    Close mega-menu

    Meetings & Events

    • Upcoming
    • Past Events

    PCORI Webinar: February 2, 2pm ET

    Hear from PCORI leaders about ways to get involved in PCOR, improvements to our funding opportunities, and more. Register

    Confronting COVID-19: A Webinar Series

    Learn more about the series and access recordings and summary reports of all six sessions.

    2020 PCORI Annual Meeting

    Watch recordings of all sessions, and view titles and descriptions of the posters presented at the virtual meeting.

You are here

  • Research & Results
  • Explore Our Portfolio
  • Can People in Later Stages of MS Stop...

Can People in Later Stages of MS Stop Taking Disease-Modifying Therapies? (The DISCO-MS Trial)

Sign Up for Updates to This Study  

Project Summary  

This research project is in progress. PCORI will post the research findings on this page within 90 days after the results are final.

What is the research about?

About 400,000 Americans have multiple sclerosis, or MS. MS is a chronic health problem that can cause fatigue, numbness, trouble with eyesight, bladder problems, and difficulty walking. With MS, the body’s immune system attacks the tissue around nerve fibers in the brain and spinal cord. When this tissue breaks down, scar tissue called lesions forms. Lesions prevent the brain from properly transmitting messages to the body. Doctors can identify these lesions using magnetic resonance imaging (MRI).

Predicting how MS will progress in each person can be hard. In early phases of MS, most people have periods of time when they have symptoms, called relapse, followed by periods of time when they have few or no symptoms, called remission. During periods of relapse, nerves can get inflamed, which can cause nerve damage.

In early phases of MS, many patients get drugs called disease-modifying therapies, or DMTs. DMTs can reduce inflammation and nerve damage. However, DMTs are less effective at treating MS in its later phases. DMTs can also be difficult to take for a long time because they are costly, can cause a variety of side effects, and have long-term health risks.

MS research suggests that risk of relapses and new lesions decreases as people age, especially in patients with MS who are 55 or older. Researchers want to learn whether patients who have had no relapse or no change in a brain MRI scan for five years can stop taking DMTs without the MS getting worse. Researchers also want to know whether there is a difference in patients’ quality of life and in how MS symptoms progress in patients who keep taking DMTs compared with patients who stop taking DMTs.

Who can this research help?

Findings from this study can help patients 55 and older with MS and their doctors decide whether to stop treatment with DMTs.

What is the research team doing?

The research team is recruiting 300 patients with MS, ages 55 and older, from 15 MS centers across the country. Patients must have had no relapse or new lesions on an MRI scan for at least five years to be eligible for the study. The team is assigning patients, by chance, to keep taking their DMT or to stop taking their DMT, with 150 people in each group. The patients and the doctors treating them know whether they are taking a DMT, but the doctors who do the brain scans and read the MRIs do not know. At any time, the patient and the patient’s doctor can decide to stop, restart, or change the DMT.

The research team is checking every six months to see whether patients have new MS activity. The team is also checking the number of new MRI lesions and changes in patients’ disabilities and quality of life.

Patients and doctors are meeting with the research team every six months to discuss study progress and provide feedback and suggestions. A patient with MS is serving on a board that monitors safety in the study.

Research methods at a glance

Design Elements Description
Design Randomized controlled trial
Population Adults with MS ages 55 and older who are taking a DMT, have not had a relapse or have not had new MRI lesions in 5 years, but have experienced a progression in their disease
Interventions/
Comparators
  • Discontinue taking DMT
  • Usual care, continue taking DMT
Outcomes

Primary: MS relapse or new brain MRI lesions

Secondary: change in disability, change in quality of life

Timeframe 2-year follow-up for primary outcome

Journal Articles

Related Articles

Multiple Sclerosis

Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies

Multiple Sclerosis

Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - Commentary

More on this Project  

Blogs

Can Some MS Patients Safely Stop Taking Medicines?
Patients frequently ask study Principal Investigator John Corboy, MD, MA: “Hey doc, how long do I need to take this?” Studies have shown that the medicines generally become less effective as patients age. With PCORI funding, Corboy’s team is looking at two groups of patients who have stopped using their medicines and continuing treatment.

Videos

Helping Patients with Multiple Sclerosis Get Answers (top-right)
John Corboy, MD, MA, says patients are the experts on multiple sclerosis and play major roles in a PCORI-funded study about the condition.

Project Details

Principal Investigator
John Corboy, MD, MA
Project Status
In progress; Enrollment complete
Project Title
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Board Approval Date
September 2015
Project End Date
March 2023
Organization
University of Colorado Denver
Year Awarded
2015
State
Colorado
Project Type
Research Project
Health Conditions  
Allergies and Immune Disorders
Immune Disorders
Neurological Disorders
Multiple Sclerosis
Intervention Strategies
Drug Interventions
Populations
Individuals with Disabilities
Older Adults
Women
Funding Announcement
Assessment of Prevention, Diagnosis, and Treatment Options
Project Budget
$6,115,558
Study Registration Information
HSRP20162107
NCT03073603
Page Last Updated: 
April 16, 2020

Research & Results

  • Explore Our Portfolio
  • Research Fundamentals
  • Research Results Highlights
  • Putting Evidence to Work
  • Peer Review
  • Evidence Synthesis
  • About Our Research

About Us

  • Our Programs
  • Governance
  • Financials and Reports
  • Procurement Opportunities
  • Our Staff
  • Our Vision & Mission
  • Contact Us

Research & Results

  • Explore Our Portfolio
  • Research Fundamentals
  • Research Results Highlights
  • Putting Evidence to Work
  • Peer Review
  • Evidence Synthesis
  • About Our Research

Engagement

  • The Value of Engagement
  • Engagement in Health Research Literature Explorer
  • Influencing the Culture of Research
  • Engagement Awards
  • Engagement Resources
  • Engage with Us

Funding Opportunities

  • What & Who We Fund
  • What You Need to Know to Apply
  • Applicant Training
  • Merit Review
  • Awardee Resources
  • Help Center

Meetings & Events

February 2
PCORI 2021 and Beyond: Opportunities for Funding and Involvement in Patient-Centered Research
February 9
Board of Governors Meeting: February 9, 2021
February 11
Advisory Panel on Patient Engagement Winter 2021 Meeting

PCORI

Footer contact address

Patient-Centered Outcomes
Research Institute

1828 L Street, NW, Suite 900
Washington, DC 20036
Phone: (202) 827-7700 | Fax: (202) 355-9558
[email protected]

Subscribe to Newsletter

Twitter Facebook LinkedIn Vimeo

© 2011-2021 Patient-Centered Outcomes Research Institute. All Rights Reserved.

Privacy Policy | Terms of Use | Trademark Usage Guidelines | Credits | Help Center